10.25.24
Melinda French Gates/ USAID announced $250 million global open call: Action for Women’s Health
Deadline to register: December 3, 2024, Deadline to submit applications January 10, 2024
New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed)
(RFA-AI-24-068)
Application due date: January 31, 2025
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
(PAR-25-078)
Application due date: Multiple dates, see announcement.
Co-infection and Cancer (R01 Clinical Trial Not Allowed) (PAR-25-082)
Application due date: Multiple dates, see announcement.
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses funding opportunities:
- R21 - Clinical Trial Optional (PAR-25-115)
Application due date: Multiple dates, see announcement. - R01 - Clinical Trial Optional (PAR-25-116)
Application due date: Multiple dates, see announcement.
Funding Opportunities
10.11.24
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-22-106)
Application due date: Multiple dates, see announcement.
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-22-109)
Application due date: Multiple dates, see announcement.
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Application due date: Multiple dates, see announcement.
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
(NOT-OD-25-002)
Office of Disease Prevention
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
(PA-25-121)
National Cancer Institute
Application Receipt Date(s): February 05, 2025
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
(PA-25-123)
National Cancer Institute
Application Receipt Date(s): February 16, 2025
Funding Opportunities
9.27.24
Meade Collaboration Travel Grants in Epidemiology 2024 - Travel funding opportunities for mid-career researchers based in Sub-Saharan African to conduct collaborative research and advance epidemiological skills.
The Fogarty International Center and the Office of AIDS Research of the U.S. National Institutes of Health (NIH) in collaboration with PEPFAR and the Bureau of Global Health Security and Development are launching the NIH/PEPFAR Local Implementation Science Network (LISN)
Deadline November 4, 2024
Security and Development are launching the NIH/PEPFAR Local Implementation Science Network (LISN) Deadline November 4, 2024
Reminder: Reporting Data Management and Sharing (DMS) Plan Activities in Research Performance Progress Reports (RPPRs) Submitted on or After October 1, 2024
(NOT-OD-24-175)
National Institutes of Health
U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS)
(R01 Clinical Trial Optional) *See eligibility
(RFA-AI-24-023)
National Institute of Allergy and Infectious Diseases
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Office of AIDS Research
Application Receipt Date(s): March 12, 2025
NIH to host course on ethical and regulatory aspects of clinical research - This course is offered to anyone interested or involved in the ethics of clinical research with human subjects. Participants represent multiple disciplines including research teams, IRB members, physicians, psychologists, nurses, social workers, administrative staff, students, and others. The course meets Wednesday mornings from 8:30 to 11:30 a.m. ET (USA) from September 25 to November 6, 2024.
Funding Opportunities
9.13.24
The 15th African Society of Human Genetics Conference. Entebbe, Uganda Feb 03-07, now accepting abstracts.
NIH Grants Policy Updates: FY2025 Edition - Registration Open for October 17, 2024 Webinar
(NOT-OD-24-170)
Office of the Director, NIH
Seed Global Health - Seed Educator Program | Deadline Nov. 1
Notice of Special Interest (NOSI): Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute
(NOT-CA-24-098)
National Cancer Institute
Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
(RFA-AG-25-031)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)
(RFA-AG-25-032)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
Funding Opportunities
8.29.24
The American Association of University Women (AAUW) is accepting applications for International Fellowships. Fellowships are awarded for full-time study or research in the United States to women who are not U.S. citizens or permanent residents.
*see eligibility requirements
Application deadline: November 15, 2024
Retirement of NIHs Automated Just-in-Time Email Notification
(NOT-OD-24-165)
National Institutes of Health
Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
(NOT-TW-24-009)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
(RFA-AI-24-057)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): December 4, 2024
Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
(RFA-AI-24-064)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): December 4, 2024
Funding Opportunities
8.23.24
Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE)
(NOT-AI-24-059)
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
(RFA-DK-25-024)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
(RFA-CA-25-011)
National Cancer Institute
Application Receipt Date(s): December 10, 2024
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
The UK National Institute for Health and Care Research is now seeking applications for their Global Health Research (GHR) – Researcher-led programs. GHR funds research that aims to improve health outcomes for the most vulnerable people in low and middle-income countries (LMICs).
Application deadline: November 6, 2024
The American Institute of Indian Studies is accepting applications for a variety of fellowships providing funding to pre- and post-doctoral scholars in pursuit of knowledge about India.
Application deadline: November 15, 2024
Funding Opportunities
8.2.24
Changes to NIH Biosketch and Other Support- NIHs Adoption of Common Forms for Biographical Sketch and Current and Pending (Other) Support by May 25, 2025
(NOT-OD-24-163)
Implementation Update for Data Management and Access Practices Under the Genomic Data Sharing Policy
(NOT-OD-24-157)
Office of the Director, NIH
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
(RFA-DA-25-024)
National Institute on Drug Abuse Application Receipt
Date(s): Multiple dates, see announcement.
Global Health Research (GHR) – Researcher-led programmes
Deadline 06 November, 2024
NIHR UK
Funding Opportunities
7.19.24
Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional)
(RFA-AI-24-049)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): December 4, 2024
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-22-106)
Application due date: Multiple dates, see announcement.
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-22-109)
Application due date: Multiple dates, see announcement.